Appropriate use criteria of left atrial appendage closure devices: latest evidences

Atrial fibrillation is the most common arrythmia and it is linked to an increased risk of stroke. Even if anticoagulation therapy reduces the rate of stroke the benefits of this therapy have to been balanced with the increased risk of hemorrhagic event. Left atrial appendage closure is a valid alternative to long term anticoagulation in patients with atrial fibrillation and high hemorrhagic risk. Actually new devices with different features have been tested and introduced progressively in the clinical practice. Improvements preprocedural imaging evaluation and the learning curve of the operators led to percutaneous left atrial appendage closure a safe and effective procedure. A good knowledge of different devices and the technique of implant is necessary for optimization percutaneous left atrial appendage closure and the reduction of complications during the acute phase and follow up.

[1]  Rui Chen,et al.  Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study‐level meta‐analysis of clinical trials , 2022, Clinical cardiology.

[2]  Ling Li,et al.  Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus , 2022, Frontiers in Cardiovascular Medicine.

[3]  M. Price,et al.  Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices. , 2022, JACC. Cardiovascular interventions.

[4]  I. Rashid,et al.  Novel cardiac magnetic resonance imaging‐based sizing for left atrial appendage closure , 2022, Journal of cardiovascular electrophysiology.

[5]  A. Deshmukh,et al.  Cardiac magnetic resonance imaging is a promising modality for left atrial appendage occlusion planning , 2022, Journal of cardiovascular electrophysiology.

[6]  J. Saw,et al.  Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device , 2022, Journal of Interventional Cardiac Electrophysiology.

[7]  M. Price,et al.  Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure. , 2022, Journal of the American College of Cardiology.

[8]  D. Sánchez-Quintana,et al.  Anatomy of the left atrial appendage for the interventional cardiologist , 2022, Herzschrittmachertherapie + Elektrophysiologie.

[9]  Bin Zhang,et al.  Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis , 2022, Cardiology.

[10]  T. Imamura,et al.  Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure , 2022, Journal of clinical medicine.

[11]  W. Abusnina,et al.  CRT-700.48 Comparative Clinical Outcomes of Left Atrial Appendage Occlusion With WATCHMAN Device Versus Amplatzer Cardiac Plug/Amulet Occluder: A Systematic Review and Meta-Analysis , 2022, JACC: Cardiovascular Interventions.

[12]  S. Garcia,et al.  In‐hospital outcomes of transesophageal versus intracardiac echocardiography guided left atrial appendage closure , 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[13]  G. Condorelli,et al.  Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE study , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  A. Micari,et al.  Real‐world experience with the new Watchman FLX device: Data from two high‐volume Sicilian centers. The FLX‐iEST registry , 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  OUP accepted manuscript , 2022, Europace.

[16]  Christopher R. Ellis,et al.  Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion. , 2021, Journal of the American College of Cardiology.

[17]  M. Hołda,et al.  Morphology of the Left Atrial Appendage: Introduction of a New Simplified Shape-Based Classification System. , 2021, Heart, lung & circulation.

[18]  He Huang,et al.  Incidence, risk factors, and clinical impact of peridevice leak following left atrial appendage closure with the LAmbre device—Data from a prospective multicenter clinical study , 2020, Journal of cardiovascular electrophysiology.

[19]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[20]  P. Neužil,et al.  Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.

[21]  Sumit K. Shah,et al.  Meta-Analysis Comparing WatchmanTM and Amplatzer Devices for Stroke Prevention in Atrial Fibrillation , 2020, Frontiers in Cardiovascular Medicine.

[22]  A. Natale,et al.  Closure of the left atrial appendage using percutaneous transcatheter occlusion devices , 2020, Journal of cardiovascular electrophysiology.

[23]  A. Natale,et al.  Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review. , 2020, JACC Clinical Electrophysiology.

[24]  M. Price,et al.  The NCDR Left Atrial Appendage Occlusion Registry. , 2020, Journal of the American College of Cardiology.

[25]  J. Saw,et al.  Periprocedural Imaging for Left Atrial Appendage Closure: Computed Tomography, Transesophageal Echocardiography, and Intracardiac Echocardiography. , 2020, Cardiac electrophysiology clinics.

[26]  J. Brachmann,et al.  Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure , 2020, Journal of cardiovascular electrophysiology.

[27]  Q. Orlandi,et al.  Transesophageal Echocardiography to Diagnose Watchman Device Infection , 2020, CASE.

[28]  G. Lippi,et al.  Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge , 2020, International journal of stroke : official journal of the International Stroke Society.

[29]  D. Delurgio,et al.  Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries. , 2019, Journal of the American College of Cardiology.

[30]  J. Brachmann,et al.  Long‐term clinical outcomes of Amplatzer cardiac plug versus Amulet occluders for left atrial appendage closure , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[31]  A. Khorana,et al.  Bleeding incidence and risk factors among cancer patients treated with anticoagulation , 2019, American journal of hematology.

[32]  J. Deux,et al.  Peridevice Leak After Left Atrial Appendage Closure: Incidence, Risk Factors, and Clinical Impact. , 2019, The Canadian journal of cardiology.

[33]  S. Raharjo,et al.  Left atrial appendage closure device implantation guided with fluoroscopy only: Long‐term results , 2019, Journal of arrhythmia.

[34]  B. Gersh,et al.  Risk stratification for stroke in atrial fibrillation: a critique , 2018, European heart journal.

[35]  P. Garot,et al.  Device-Related Thrombus After Left Atrial Appendage Closure , 2018, Interventional cardiology.

[36]  Dhanunjaya R. Lakkireddy,et al.  Long term outcomes after left atrial appendage closure with the LARIAT device—Stroke risk reduction over five years follow-up , 2018, PloS one.

[37]  M. Alkhouli,et al.  Incidence and Clinical Impact of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion: A Meta-Analysis. , 2018, JACC. Clinical electrophysiology.

[38]  D. Holmes,et al.  Intracardiac Echocardiography in Structural Heart Disease Interventions. , 2018, JACC. Cardiovascular interventions.

[39]  E. Pokushalov,et al.  Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[40]  S. Cook,et al.  Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience. , 2018, JACC. Cardiovascular interventions.

[41]  C. Tondo,et al.  Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry. , 2018, JACC. Cardiovascular interventions.

[42]  Pascal Defaye,et al.  Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. , 2018, Journal of the American College of Cardiology.

[43]  K. Cao,et al.  STRUCTURAL : ATRIAL INTERVENTION FOCUS Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation A Prospective , Multicenter Clinical Study , 2022 .

[44]  Saibal Kar,et al.  5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. , 2017, Journal of the American College of Cardiology.

[45]  S. Kische,et al.  Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. , 2017, Heart rhythm.

[46]  W. Schillinger,et al.  Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry). , 2017, The American journal of cardiology.

[47]  K. Kofoed,et al.  A comparative study of different imaging modalities for successful percutaneous left atrial appendage closure , 2017, Open Heart.

[48]  J. Brachmann,et al.  Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome , 2017, Journal of cardiovascular electrophysiology.

[49]  Thomas Song,et al.  Application of 3-Dimensional Computed Tomographic Image Guidance to WATCHMAN Implantation and Impact on Early Operator Learning Curve: Single-Center Experience. , 2016, JACC. Cardiovascular interventions.

[50]  G. Lip,et al.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[51]  A. Hobbs,et al.  Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. , 2016, International journal of cardiology.

[52]  M. Price,et al.  Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device. , 2016, JACC. Cardiovascular interventions.

[53]  Francesca Pistoia,et al.  The Epidemiology of Atrial Fibrillation and Stroke. , 2016, Cardiology clinics.

[54]  Roshan Prakash,et al.  Comparing Measurements of CT Angiography, TEE, and Fluoroscopy of the Left Atrial Appendage for Percutaneous Closure , 2016, Journal of cardiovascular electrophysiology.

[55]  B. Meier,et al.  Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. , 2016, International journal of cardiology.

[56]  Hyuk-Jae Chang,et al.  Predicting Peri-Device Leakage of Left Atrial Appendage Device Closure Using Novel Three-Dimensional Geometric CT Analysis , 2015, Journal of cardiovascular ultrasound.

[57]  Randall J. Lee,et al.  Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design. , 2015, American heart journal.

[58]  P. Mclaughlin,et al.  Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. , 2015, European heart journal cardiovascular Imaging.

[59]  S. Willems,et al.  Left Atrial Appendage Closure Guided by Integrated Echocardiography and Fluoroscopy Imaging Reduces Radiation Exposure , 2015, PloS one.

[60]  Saibal Kar,et al.  Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. , 2015, Journal of the American College of Cardiology.

[61]  Saibal Kar,et al.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.

[62]  O. Alfieri,et al.  Persistent lone atrial fibrillation: clinicopathologic study of 19 cases. , 2014, Heart rhythm.

[63]  Hiroshi Ashikaga,et al.  Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. , 2013, Heart rhythm.

[64]  Petr Neuzil,et al.  Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.

[65]  Y. Lam A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation. , 2013, Cardiovascular revascularization medicine : including molecular interventions.

[66]  Sanghamitra Mohanty,et al.  Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. , 2012, Journal of the American College of Cardiology.

[67]  R. Mahajan,et al.  Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure , 2012, Heart.

[68]  G. Lip,et al.  Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. , 2011, Age and ageing.

[69]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[70]  C. Asher,et al.  Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trial. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[71]  M. Main,et al.  Transesophageal echocardiographic diagnosis of left atrial appendage occluder device infection. , 2007, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[72]  D. Schwartzman,et al.  Dynamic multidimensional imaging of the human left atrial appendage. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[73]  Carl van Walraven,et al.  Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. , 2002, JAMA.

[74]  W. Manning,et al.  Accuracy of Transesophageal Echocardiography for Identifying Left Atrial Thrombi: A Prospective, Intraoperative Study , 1995, Annals of Internal Medicine.

[75]  G. Lip Does atrial fibrillation confer a hypercoagulable state? , 1995, The Lancet.

[76]  C. Pollick,et al.  Assessment of Left Atrial Appendage Function by Transesophageal Echocardiography: Implications for the Development of Thrombus , 1991, Circulation.

[77]  A. Weyman,et al.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.